🔎 Trials Near Me

Home › Coronary Artery Disease › Oklahoma › Oklahoma City

Coronary Artery Disease clinical trials in Oklahoma City, OK

6 studies for Coronary Artery Disease are looking for participants at sites in and around Oklahoma City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention

RecruitingPhase 4
  • South Oklahoma Heart Research, LLC, Oklahoma City
Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06909565

A Phase 2b Clinical Trial of YN001 in Adults With Coronary Atherosclerosis

RecruitingPhase 2
  • South Oklahoma Heart Research, LLC, Oklahoma City
Ages 18 to 80 · All sexes · Updated Sep 22, 2026 · NCT07521007

Prospective Global Registry for the Study of Chronic Total Occlusion Intervention

RecruitingObservational study
  • Oklahoma City VA Medical Center, Oklahoma City
All ages · All sexes · Updated Aug 19, 2026 · NCT02061436

MagicTouch™Sirolimus-Coated Balloon for Treatment of Coronary Artery Lesions in Small Vessels

Recruiting
  • University of Oklahoma Health Science Center, Oklahoma City
Ages 18 to 80 · All sexes · Updated Sep 11, 2025 · NCT06271590

MagicTouch for Treatment of In-Stent Restenosis in Coronary Artery Lesions

Recruiting
  • Oklahoma University Health (OU Health), Oklahoma City
Ages 18 to 110 · All sexes · Updated Feb 25, 2025 · NCT05908331

About Coronary Artery Disease

Coronary artery disease (CAD) is the most common type of heart disease. It can lead to angina and heart attack. Read about symptoms and tests.

More about Coronary Artery Disease on MedlinePlus

Coronary Artery Disease trials in other cities

Other studies in Oklahoma City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.